Morningstar Advisor - October/November 2012 - (Page 46)
By Shannon Zimmerman
There’s more, and less, than meets the eye in momentum’s longterm track record.
Despite ample evidence that momentumbased strategies work, fundamentally focused investors are often dismissive of them. Momentum gets a bad rap in part because it can be turnover intensive and, therefore, expensive to execute. For many fundamentalists, moreover, it simply seems too easy. Rather than poring over a company’s financials, assessing its executives, constructing elaborate valuation models, and forecasting earnings-growth rates for periods of up to a decade, momentum investors ask a single question—what’s working now?—and place their trades. There are variations on the approach. Some momentum strategies incorporate earnings data and relative strength among their criteria, for example. But one remarkably simple version of the tactic has enjoyed outsize success. In “Momentum–A Contrarian Case for Following the Herd,” a white paper published in 2010, Tom Hancock, co-head of GMO’s global quantitative equity team, found that between 1927 and 2009, a strategy of investing in the top quartile of stocks based on trailing 12-month returns outperformed the market by an annualized 3%. One common price momentum variant—excluding returns generated in the 12th month of the time series and re-sorting the date to identify top performers—surpassed the market’s return by an annualized 4%.
Hancock’s results are consistent with earlier findings of excess returns that can be explained by momentum. The website of Kenneth French is a standard resource for academic momentum research; it provides downloadable spreadsheets documenting the factor’s outperformance between January 1927 and December 2011 using monthly and annual returns. Using daily returns, French also finds excess returns for the tactic between July 1963 and December 2011. Jegadeesh and Titman (1993) and Carhart (1997) also wrote groundbreaking papers on momentum. Other researchers have examined the impact of momentum in non-U.S. markets, finding excess returns also persist abroad. Dimson, Marsh, and Staunton (2008), for example, have documented outperformance in the United Kingdom between 1900 and 2007. And in “Value and Momentum Everywhere,” Asness, Moskowitz, and Pedersen (2009) provide a useful overview of research into whether momentum’s outperformance transcends asset classes as well as geographic boundaries. It does, they find.
Risks & Rewards
points, for example, and the strategy took drubbings not only during 2008’s dramatic sell-off but also in 2009’s dramatic recovery. Momentum returned to historical form in 2010’s comparatively calmer waters, though, with each of the momentum-based indexes created and tracked by quant researcher AQR besting the relevant benchmarks. Unsurprisingly, AQR Momentum AMOMX, a pure, institutional play on the strategy, also delivered a strong year. That large-growth fund surpassed its average rival by more than 3 percentage points in 2010, en route to a total return that year of 18.6%. Launched in July 2009, AQR Momentum has earned a Morningstar Analyst Rating of Bronze, and its annualized gain of 14.4% in the trailing three years through August places in the peer group’s top quartile. It ranks in the top quartile for the year-to-date period, a stretch in which the fund has surpassed not only the category norm but also its Russell 1000 and Russell 1000 Growth Index benchmarks.
Secrets of Success
Those are impressive results, yet trends that look linear and persistent over a lengthy time frame are typically far more jagged on closer inspection. So it is with momentum. The tactic is especially vulnerable to market inflection
Glancing at the AQR fund’s portfolio, investors might conclude that its recent success owes to bets on technology and consumer discretionary stocks, the two best-performing areas of the market so far in 2012. The fund is also light on the year’s worst performers, energy and utilities.
46 Morningstar Advisor October/November 2012
Table of Contents for the Digital Edition of Morningstar Advisor - October/November 2012
Morningstar Advisor - October/November 2012
Letter From the Editor
Do You Use Factor-Investing Strategies?
Practicing What She Preaches
How to Determine the True Price of ETFs
The Quant Factor
Managers Dispute the Death of Equities
Investments á la Carte
Five Inconvenient Truths of Manager Research
Health Care’s Outlook Clarifies
Exploring the World of Factors
Uncloaking the Alpha Machine
Factor Strategies Gain Footholds in Practices
Fitting Factors Into the Formula
Clients Have a Friend in Luther King
Less-Liquid Holdings Mean More-Solid Results
Retirement-Withdrawal Strategies Quantified
Amid Turmoil, Don’t Discount Foreign Equities
Our Favorite Mutual Funds
50 Most-Popular Equity ETFs
Undervalued Stocks With Wide Moats
Should I Stay or Should I Go?
Morningstar Advisor - October/November 2012